Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Cosmo Pharmaceuticals N.V.    COPN   NL0011832936

COSMO PHARMACEUTICALS N.V.

(COPN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company usually posts poor financials for mid or long term investments.
Strengths
  • Historically, the company has been releasing figures that are above expectations.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • Low profitability weakens the company.
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
COSMO PHARMACEUTICALS N.V.10.17%1 356
JOHNSON & JOHNSON-0.82%380 876
ROCHE HOLDING AG-4.76%282 467
PFIZER, INC.3.21%212 942
NOVARTIS AG-10.48%206 479
MERCK & CO., INC.-11.61%203 389
ABBVIE INC.18.12%184 633
NOVO NORDISK A/S8.55%155 951
BRISTOL-MYERS SQUIBB COMPAN..-2.79%141 008
ASTRAZENECA PLC2.54%136 635
ELI LILLY AND COMPANY10.82%132 044
AMGEN INC.-6.63%129 265
SANOFI-6.16%127 199
GLAXOSMITHKLINE PLC-22.37%90 971
CHUGAI PHARMACEUTICAL CO., ..50.12%79 458
JIANGSU HENGRUI MEDICINE CO..17.90%69 083
More Results
Financials
Sales 2020 53,1 M 64,2 M 64,2 M
Net income 2020 -8,53 M -10,3 M -10,3 M
Net cash 2020 51,0 M 61,6 M 61,6 M
P/E ratio 2020 -132x
Yield 2020 -
Capitalization 1 125 M 1 356 M 1 359 M
EV / Sales 2020 20,2x
EV / Sales 2021 16,7x
Nbr of Employees 261
Free-Float 45,8%
Upcoming event on COSMO PHARMACEUTICALS N.V.
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation -
Finances -
Profitability
Earnings quality
Business Predictability
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes